BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28064058)

  • 1. Pectin-zinc-chitosan-polyethylene glycol colloidal nano-suspension as a food grade carrier for colon targeted delivery of resveratrol.
    Andishmand H; Tabibiazar M; Mohammadifar MA; Hamishehkar H
    Int J Biol Macromol; 2017 Apr; 97():16-22. PubMed ID: 28064058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
    Natesan S; Pandian S; Ponnusamy C; Palanichamy R; Muthusamy S; Kandasamy R
    Int J Biol Macromol; 2017 Nov; 104(Pt B):1837-1845. PubMed ID: 28472691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of zinc-pectin-chitosan composite particles for drug delivery to the colon: role of chitosan in modifying in vitro and in vivo drug release.
    Das S; Chaudhury A; Ng KY
    Int J Pharm; 2011 Mar; 406(1-2):11-20. PubMed ID: 21168477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
    Amin MK; Boateng JS
    Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
    [No Abstract]   [Full Text] [Related]  

  • 5. An integrated buccal delivery system combining chitosan films impregnated with peptide loaded PEG-b-PLA nanoparticles.
    Giovino C; Ayensu I; Tetteh J; Boateng JS
    Colloids Surf B Biointerfaces; 2013 Dec; 112():9-15. PubMed ID: 23928054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
    Pawar H; Douroumis D; Boateng JS
    Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
    Giovino C; Ayensu I; Tetteh J; Boateng JS
    Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of 5-fluorouracil and shikonin by blended and coated chitosan/pectin nanoparticles for treatment of colon cancer.
    Daneshmehr M; Pazhang M; Mollaei S; Ebadi M; Pazhang Y
    Int J Biol Macromol; 2024 Jun; 270(Pt 2):132413. PubMed ID: 38761911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon-specific delivery of resveratrol: optimization of multi-particulate calcium-pectinate carrier.
    Das S; Ng KY
    Int J Pharm; 2010 Jan; 385(1-2):20-8. PubMed ID: 19833179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Colonic Delivery of DsiRNA by Pectin-Coated Polyelectrolyte Complex Nanoparticles: Preparation, Characterization and Improved Gastric Survivability.
    Hussain Z; Katas H; Yan SL; Jamaludin D
    Curr Drug Deliv; 2017; 14(7):1016-1027. PubMed ID: 28240178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurine loaded chitosan-pectin nanoparticle shows curative effect against acetic acid-induced colitis in rats.
    Ahmed O; Abdel-Halim M; Farid A; Elamir A
    Chem Biol Interact; 2022 Jan; 351():109715. PubMed ID: 34695389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrostatic Self-Assembled Chitosan-Pectin Nano- and Microparticles for Insulin Delivery.
    Maciel VBV; Yoshida CMP; Pereira SMSS; Goycoolea FM; Franco TT
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29023400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
    Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD
    Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and in vitro/in vivo evaluation of Zn-pectinate microparticles reinforced with chitosan for the colonic delivery of progesterone.
    Gadalla HH; Soliman GM; Mohammed FA; El-Sayed AM
    Drug Deliv; 2016 Sep; 23(7):2541-2554. PubMed ID: 25853478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of glutaraldehyde on in vivo colon-specific release of resveratrol from biodegradable pectin-based formulation.
    Das S; Ng KY
    J Pharm Sci; 2010 Dec; 99(12):4903-16. PubMed ID: 20572052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations.
    Das S; Ng KY; Ho PC
    J Drug Target; 2011 Jul; 19(6):446-57. PubMed ID: 20684731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen.
    Hassani Najafabadi A; Abdouss M; Faghihi S
    Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():91-9. PubMed ID: 24907742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite.
    Yuk SH; Oh KS; Cho SH; Kim SY; Oh S; Lee JH; Kim K; Kwon IC
    Mol Pharm; 2012 Feb; 9(2):230-6. PubMed ID: 22149139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.